This past week, a follow-up letter was received from Marion Law, the Director General of Health Canada’s Therapeutic Products Directorate (TPD) addressing discussions during the Oct 31 meeting with Janssen, CADDAC and ADHD medical experts. The letter
Read moreOn October the 31st CADDAC and CADDRA, as well as other stake holders, met with Health Canada to present our activities over the past six years and express our continued concerns in regards to the bioequivalency, or more accurately the lack of therapeu
Read moreThe content of CADDAC’s new paper on the impact of ADHD in the Canadian Justice system was recently featured on CBC Radio’s “The Current”. The half hour segment featured three interviews: a young offender diagnosed after several incarcerations, Heidi B
Read moreSince CADDAC continues to receive feedback from our stakeholders about reduced symptom coverage and/or increased side effects they are experiencing with the generic forms of Concerta available in Canada we are keeping you updated on what is occurring s
Read moreThe content of CADDAC's new paper on the impact of ADHD in the Canadian Justice system was recently featured on CBC Radio's "The Current". The half hour segment featured three interviews, a young offender diagnosed after several incarcerations, Heidi B
Read moreThe Center for ADHD Canada is drawing attention to an issue of importance that has long been ignored by the Canadian justice system during October, ADHD Awareness month. Incident rates of ADHD in the correctional population are 5 times greater than wha
Read more